1245 related articles for article (PubMed ID: 29398179)
1. Update on Diabetic Nephropathy: Core Curriculum 2018.
Umanath K; Lewis JB
Am J Kidney Dis; 2018 Jun; 71(6):884-895. PubMed ID: 29398179
[TBL] [Abstract][Full Text] [Related]
2. Effects of renin-angiotensin system blockers on renal and cardiovascular outcomes in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials.
Liu X; Ma L; Li Z
J Endocrinol Invest; 2020 Jul; 43(7):959-972. PubMed ID: 31939197
[TBL] [Abstract][Full Text] [Related]
3. To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease.
St Peter WL; Odum LE; Whaley-Connell AT
Pharmacotherapy; 2013 May; 33(5):496-514. PubMed ID: 23576066
[TBL] [Abstract][Full Text] [Related]
4. Treatment of type 2 diabetic nephropathy by blockade of the renin-angiotensin system: a comparison of angiotensin-converting-enzyme inhibitors and angiotensin receptor antagonists.
Hsueh WA
Curr Opin Pharmacol; 2002 Apr; 2(2):182-8. PubMed ID: 11950631
[TBL] [Abstract][Full Text] [Related]
5. The reno-protective effect of the dual blockade of the renin angiotensin system (RAS).
Luno J; Praga M; de Vinuesa SG
Curr Pharm Des; 2005; 11(10):1291-300. PubMed ID: 15853685
[TBL] [Abstract][Full Text] [Related]
6. Individualized prediction of the effect of angiotensin receptor blockade on renal and cardiovascular outcomes in patients with diabetic nephropathy.
van der Sande NG; Dorresteijn JA; Visseren FL; Dwyer JP; Blankestijn PJ; van der Graaf Y; Heerspink HL
Diabetes Obes Metab; 2016 Nov; 18(11):1120-1127. PubMed ID: 27337598
[TBL] [Abstract][Full Text] [Related]
7. Effect of dual compared to no or single renin-angiotensin system blockade on risk of renal replacement therapy or death in predialysis patients: PREPARE-2 study.
Voskamp PWM; Dekker FW; van Diepen M; Hoogeveen EK;
J Am Soc Hypertens; 2017 Oct; 11(10):635-643. PubMed ID: 28802945
[TBL] [Abstract][Full Text] [Related]
8. Mineralocorticoid receptor blockade in addition to angiotensin converting enzyme inhibitor or angiotensin II receptor blocker treatment: an emerging paradigm in diabetic nephropathy: a systematic review.
Mavrakanas TA; Gariani K; Martin PY
Eur J Intern Med; 2014 Feb; 25(2):173-6. PubMed ID: 24315413
[TBL] [Abstract][Full Text] [Related]
9. The renin-angiotensin system and diabetic nephropathy.
Gurley SB; Coffman TM
Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.
Pisoni R; Faraone R; Ruggenent P; Remuzzi G
J Nephrol; 2002; 15(4):428-30. PubMed ID: 12243375
[TBL] [Abstract][Full Text] [Related]
11. Effect of dual blockade of the renin-angiotensin system on the progression of type 2 diabetic nephropathy: a randomized trial.
Fernandez Juarez G; Luño J; Barrio V; de Vinuesa SG; Praga M; Goicoechea M; Cachofeiro V; Nieto J; Fernández Vega F; Tato A; Gutierrez E;
Am J Kidney Dis; 2013 Feb; 61(2):211-8. PubMed ID: 22939518
[TBL] [Abstract][Full Text] [Related]
12. Treatment of diabetic nephropathy with angiotensin II blockers.
Sonkodi S; Mogyorósi A
Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v21-3. PubMed ID: 12817061
[TBL] [Abstract][Full Text] [Related]
13. Dual blockade of the renin-angiotensin system in diabetic nephropathy.
Wade VL; Gleason BL
Ann Pharmacother; 2004; 38(7-8):1278-82. PubMed ID: 15187210
[TBL] [Abstract][Full Text] [Related]
14. [Risk and prevention of diabetic nephropathy].
Ravera M; Re M; Deferrari G
G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
[TBL] [Abstract][Full Text] [Related]
15. Update on role of direct renin inhibitor in diabetic kidney disease.
Dhakarwal P; Agrawal V; Kumar A; Goli KM; Agrawal V
Ren Fail; 2014 Jul; 36(6):963-9. PubMed ID: 24678880
[TBL] [Abstract][Full Text] [Related]
16. Dual renin-angiotensin system blockade for nephroprotection.
Ruggenenti P
Nephrol Ther; 2017 Apr; 13 Suppl 1():S43-S45. PubMed ID: 28577742
[TBL] [Abstract][Full Text] [Related]
17. Novel effective drugs for diabetic kidney disease? or not?
Gentile G; Mastroluca D; Ruggenenti P; Remuzzi G
Expert Opin Emerg Drugs; 2014 Dec; 19(4):571-601. PubMed ID: 25376947
[TBL] [Abstract][Full Text] [Related]
18. Dual blockade of the renin angiotensin system in diabetic and nondiabetic kidney disease.
Andersen NH; Mogensen CE
Curr Hypertens Rep; 2004 Oct; 6(5):369-76. PubMed ID: 15341690
[TBL] [Abstract][Full Text] [Related]
19. Outcome studies in diabetic nephropathy.
Mohanram A; Toto RD
Semin Nephrol; 2003 May; 23(3):255-71. PubMed ID: 12838494
[TBL] [Abstract][Full Text] [Related]
20. Management of Hypertension in Diabetic Nephropathy: How Low Should We Go?
Sternlicht H; Bakris GL
Blood Purif; 2016; 41(1-3):139-43. PubMed ID: 26766168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
